Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos Alvarez

Showing results (371-380 of 440) with videos related to

Pageof 44
Sort By:
Protein Science : a Publication of the Protein Society|December 22, 2016
Disrupting a key hydrophobic pair in the oligomerization interface of the actinoporins impairs their pore-forming activityHaydeé Mesa-Galloso, Karelia H Delgado-Magnero, Sheila Cabezas, et al.
Early Human Development|May 31, 2015
Maternal PPARG Pro12Ala polymorphism is associated with infant's neurodevelopmental outcomes at 18 months of ageFrancisco J Torres-Espínola, Signe Altmäe, Maria Teresa Segura, et al.
Nature Communications|December 4, 2021
Therapeutic vulnerability to PARP1,2 inhibition in RB1-mutant osteosarcomaGeorgia Zoumpoulidou, Carlos Alvarez-Mendoza, Caterina Mancusi, et al.
The Science of the Total Environment|November 11, 2024
Inventories of plastic pollution sources, flows and hotspots as a baseline for national action plans: The experience of MexicoAlethia Vázquez-Morillas, Juan Carlos Alvarez-Zeferino, Arely Areanely Cruz-Salas, et al.
Protein Engineering, Design & Selection : PEDS|February 8, 2011
Validation of a mutant of the pore-forming toxin sticholysin-I for the construction of proteinase-activated immunotoxinsDavid Pentón, Victor Pérez-Barzaga, Iscel Díaz, et al.
Gaceta Sanitaria|June 15, 2010
[Gender inequalities in the Spanish Public Health and Health Administration Society (2000-2009)]Joana Morrison, Carme Borrell, Marc Marí-Dell'Olmo, et al.
Drugs & Aging|May 7, 2013
The quality of quality measures: HEDIS® quality measures for medication management in the elderly and outcomes associated with new exposureMary Jo V Pugh, Zachary A Marcum, Laurel A Copeland, et al.
Cancers|April 17, 2020
SOX2 Expression and Transcriptional Activity Identifies a Subpopulation of Cancer Stem Cells in Sarcoma with Prognostic ImplicationsSofia T Menendez, Veronica Rey, Lucia Martinez-Cruzado, et al.
The Pediatric Infectious Disease Journal|January 10, 2025
Comorbidities Associated With Different Degrees of Severity in Children and Young People Hospitalized With Acute COVID-19Irati Gastesi, Sara Domínguez-Rodríguez, Marthe Le Prevost, et al.
Investigational New Drugs|August 6, 2013
Reduced folate carrier (RFC) as a predictive marker for response to pemetrexed in advanced non-small cell lung cancer (NSCLC)Carlos Alvarez-Fernandez, Quionia Perez-Arnillas, Lucrecia Ruiz-Echeverria, et al.
Pageof 44

Showing results (371-380 of 440) with videos related to

Sort By:
Pageof 44
Protein Science : a Publication of the Protein Society|December 22, 2016
Disrupting a key hydrophobic pair in the oligomerization interface of the actinoporins impairs their pore-forming activityHaydeé Mesa-Galloso, Karelia H Delgado-Magnero, Sheila Cabezas, et al.
Early Human Development|May 31, 2015
Maternal PPARG Pro12Ala polymorphism is associated with infant's neurodevelopmental outcomes at 18 months of ageFrancisco J Torres-Espínola, Signe Altmäe, Maria Teresa Segura, et al.
Nature Communications|December 4, 2021
Therapeutic vulnerability to PARP1,2 inhibition in RB1-mutant osteosarcomaGeorgia Zoumpoulidou, Carlos Alvarez-Mendoza, Caterina Mancusi, et al.
The Science of the Total Environment|November 11, 2024
Inventories of plastic pollution sources, flows and hotspots as a baseline for national action plans: The experience of MexicoAlethia Vázquez-Morillas, Juan Carlos Alvarez-Zeferino, Arely Areanely Cruz-Salas, et al.
Protein Engineering, Design & Selection : PEDS|February 8, 2011
Validation of a mutant of the pore-forming toxin sticholysin-I for the construction of proteinase-activated immunotoxinsDavid Pentón, Victor Pérez-Barzaga, Iscel Díaz, et al.
Gaceta Sanitaria|June 15, 2010
[Gender inequalities in the Spanish Public Health and Health Administration Society (2000-2009)]Joana Morrison, Carme Borrell, Marc Marí-Dell'Olmo, et al.
Drugs & Aging|May 7, 2013
The quality of quality measures: HEDIS® quality measures for medication management in the elderly and outcomes associated with new exposureMary Jo V Pugh, Zachary A Marcum, Laurel A Copeland, et al.
Cancers|April 17, 2020
SOX2 Expression and Transcriptional Activity Identifies a Subpopulation of Cancer Stem Cells in Sarcoma with Prognostic ImplicationsSofia T Menendez, Veronica Rey, Lucia Martinez-Cruzado, et al.
The Pediatric Infectious Disease Journal|January 10, 2025
Comorbidities Associated With Different Degrees of Severity in Children and Young People Hospitalized With Acute COVID-19Irati Gastesi, Sara Domínguez-Rodríguez, Marthe Le Prevost, et al.
Investigational New Drugs|August 6, 2013
Reduced folate carrier (RFC) as a predictive marker for response to pemetrexed in advanced non-small cell lung cancer (NSCLC)Carlos Alvarez-Fernandez, Quionia Perez-Arnillas, Lucrecia Ruiz-Echeverria, et al.
Pageof 44